Back
Minerva Neurosciences, Inc. 10K Form
Sell
48
NERV
Minerva Neurosciences, Inc.
Last Price:
$4.05
Seasonality Move:
-7.64%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NERV News And Ratings
See the #1 stock for the next 7 days that we like better than NERV
NERV Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-2.9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-4.94 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -1.85320 |
|---|---|
| Net Income (TTM): | $-14M |
| Gross Margin: | $-22.5K |
| Return on Equity: | 0% |
| Return on Assets: | -40.95% |
Minerva Neurosciences, Inc. Earnings Forecast
Key Minerva Neurosciences, Inc. Financial Ratios
-
The Interest Expense is 317.06% of Operating Income.
-
Per Share Earnings over the last 13 years have been positive in 7 years.
Minerva Neurosciences, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | NERV |
| CUSIP: | 603380 |
| Website: | minervaneurosciences.com |
Debt
| Debt-to-Equity Ratio: | -1.74 |
|---|---|
| Current Ratio: | 4.87 |
| Quick Ratio: | 4.64 |
Price-to-Earnings
| Trailing P/E Ratio: | 21.47 |
|---|---|
| Forward P/E Ratio: | 0 |
NERV Technical Analysis vs Fundamental Analysis
Sell
48
Minerva Neurosciences, Inc. (NERV)
is a Sell
Is Minerva Neurosciences, Inc. a Buy or a Sell?
-
Minerva Neurosciences, Inc. stock is rated a SellThe current Minerva Neurosciences, Inc. [NERV] share price is $4.08. The Score for NERV is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.